Last Updated on eMC 22-02-2016 View medicine  | GlaxoSmithKline Consumer Healthcare Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Reasons for adding or updating:

  • Company name change or merger

Reasons for adding or updating:

  • Change to section 6 - what the product contains

Reasons for adding or updating:

  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC